A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

NCT06980480 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma
Secondary Immunodeficiency

Interventions

BIOLOGICAL: IGI, 10%

Sponsor

Takeda

Collaborators

[object Object]
[object Object]